Online citations, reference lists, and bibliographies.

Enhanced Endoscopy In Bladder Cancer

Shane M Pearce, Siamak Daneshmand
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose of ReviewEndoscopy coupled with targeted resections represents a cornerstone in the diagnosis, staging, and treatment of patients with bladder cancer. Direct visualization can be challenging and imprecise due to patient-, tumor-, and surgeon-specific factors. We will review contemporary endoscopic technologies and techniques used to improve our ability to safely identify and resect malignant lesions in patients with bladder cancer.Recent FindingsEnhanced endoscopic imaging technology may improve detection rates for bladder cancer throughout the upper and lower urinary tract, which may lead to improvements in recurrence and progression rates for non-muscle invasive bladder cancer (NMIBC). New techniques including narrow-band imaging (NBI), photodynamic diagnosis (PDD), Storz Professional Image Enhancement System (SPIES), optical coherence tomography (OCT), and others have shown benefit and may further improve our ability to detect and stage bladder tumors.SummaryEnhanced endoscopy technologies have already demonstrated value in improving the sensitivity of bladder cancer detection and early results suggest they may improve short- and long-term oncologic outcomes.
This paper references
The development of the cystoscope. From "lichtleiter" to fiber optics.
Winston W. Scott (1969)
10.1007/s00345-016-1925-0
Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III
Thorsten Bach (2016)
10.1016/S0090-4295(94)80203-3
Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
Pia Steinbach (1994)
10.1117/1.3171943
Wavelet analysis enables system-independent texture analysis of optical coherence tomography images.
Colleen A. Lingley-Papadopoulos (2009)
10.1016/j.pdpdt.2015.08.002
Photodynamic diagnostic ureterorenoscopy: A valuable tool in the detection of upper urinary tract tumour.
Slawomir Grzegorz Kata (2016)
10.1111/j.1464-410X.2008.08244.x
Two centuries of cystoscopy: the development of imaging, instrumentation and synergistic technologies.
Mary K Samplaski (2009)
10.1016/j.urology.2016.11.032
Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study.
Ditte Drejer (2017)
10.1002/cncr.28905
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
10.1016/j.urology.2008.02.002
Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Alvin C. Goh (2007)
10.1089/end.2015.0523
A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.
Daniel Le Bui (2015)
10.1007/s00345-016-1859-6
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma
Rao S. Mandalapu (2016)
10.1089/END.2016.0804
Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy.
PagliaruloVincenzo (2017)
10.3892/mco.2018.1566
Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis.
Juan Huang (2018)
10.1007/s00345-015-1485-8
Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy
Georgios Gakis (2015)
10.1016/S0022-5347(01)63691-7
The development of the cystoscope.
Matthias A. Reuter (1998)
10.1016/j.juro.2017.11.096
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Siamak Daneshmand (2018)
10.1016/j.urolonc.2017.06.002
Follow-up of high-risk bladder cancer-Is it safe to perform fluorescence endoscopy multiple times in the same patient?
Maria Apfelbeck (2017)
10.1007/s11934-017-0680-0
Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies
Daniel Zainfeld (2017)
10.4111/icu.2018.59.2.98
Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy
Seung Bin Kim (2018)
10.1016/j.gie.2013.09.020
In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video).
Marcia Irene Canto (2014)
10.1007/s00345-017-2077-6
‘Real-life experience’: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC—a prospective controlled study
Kevin Michael Gallagher (2017)
10.1007/s00120-018-0624-4
[Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].
Giorgos Gakis (2019)
10.1089/end.2015.0687
Comparing Image Perception of Bladder Tumors in Four Different Storz Professional Image Enhancement System Modalities Using the íSPIES App.
Guido Kamphuis (2016)
10.1016/j.aju.2017.01.003
Photodynamic diagnosis in upper urinary tract urothelial carcinoma: A systematic review
Elsawi Medani Osman (2017)
10.1016/j.eururo.2014.06.037
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
J. Alfred Witjes (2014)
10.3233/BLC-160048
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
Ashish M. Kamat (2016)
10.1371/journal.pone.0170819
A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
Yiquan Xiong (2017)
10.1117/1.2904987
Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis.
Colleen A. Lingley-Papadopoulos (2008)
10.1038/nrurol.2014.245
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
Siamak Daneshmand (2014)
10.3322/caac.21442
Cancer statistics, 2018.
Rebecca L Siegel (2018)
10.1590/S1677-5538.IBJU.2016.0324
Evaluation of the Spies™ modalities image quality
Esteban Emiliani (2017)
10.1016/S0090-4295(94)80167-3
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid.
Martin Kriegmair (1994)
10.1016/j.urology.2009.04.090
Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography.
Hugang Ren (2009)
10.2196/resprot.8862
Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies
Esmee Iml Liem (2018)
10.1016/j.eururo.2013.07.007
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Michael Rink (2013)
10.1016/j.eururo.2009.07.042
Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
Jörg Schmidbauer (2009)
10.1364/BOE.7.003721
Classification of basal cell carcinoma in human skin using machine learning and quantitative features captured by polarization sensitive optical coherence tomography.
Tahereh Marvdashti (2016)
10.1089/cren.2017.0114
Probe-Based Confocal Laser Endomicroscopy Using Acrinol as a Novel Dye Can Be Used to Observe Cancer Nuclei of Bladder Carcinoma In Situ
Yoshio Naya (2018)
10.3322/caac.21442
Cancer statistics, 2018
Rebecca L. Siegel Mph (2018)
10.1089/end.2016.0892
Urothelial Tumors and Dual-Band Imaging: A New Concept in Confocal Laser Endomicroscopy.
Arnaud Marien (2017)
10.1186/s12885-015-1571-8
A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging
Joo Yong Lee (2015)
10.1016/j.juro.2016.10.061
Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta‐Analysis
Roger Chou (2017)
10.1016/j.urolonc.2010.09.009
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder.
Seth P. Lerner (2012)
10.1089/clm.1996.14.59
Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.
Stuart L. Marcus (1996)
10.1371/journal.pone.0074142
Therapeutic Outcome of Fluorescence Cystoscopy Guided Transurethral Resection in Patients with Non-Muscle Invasive Bladder Cancer: A Meta-Analysis of Randomized Controlled Trials
Haichao Yuan (2013)
10.1016/0090-4295(82)90065-6
Problems encountered by early endoscopists.
Patricia Nicholson (1982)
10.1089/end.2014.1651
The Storz professional image enhancement system(spies) nonmuscle-invasive bladder cancer study:a multicenter international randomized controlled study.
Stavros Gravas (2014)
Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis.
Petru Octavian Drăgoescu (2017)
10.1089/end.2005.19.570
Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography.
Michael J. Manyak (2005)
10.2165/00019053-200321180-00003
The health economics of bladder cancer: a comprehensive review of the published literature.
Marc F Botteman (2003)
10.1016/j.juro.2010.05.087
Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography.
Hugang Ren (2010)
10.1016/S0090-4295(97)00645-6
Harold Hopkins and optical systems for urology--an appreciation.
J. G. Gow (1998)
10.1007/s00345-009-0395-z
Economic aspects of bladder cancer: what are the benefits and costs?
K. D. Sievert (2009)
Photodynamic diagnosis following topical application of delta-aminolevulinic acid in a rat bladder tumor model.
Martin Kriegmair (1994)
10.18632/oncotarget.13054
Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis
Weiting Kang (2017)
10.1002/1097-0142(196412)17:12<1528::AID-CNCR2820171203>3.0.CO;2
TETRACYCLINE ULTRAVIOLET FLUORESCENCE IN BLADDER CARCINOMA.
Willet F. Whitmore (1964)
10.1111/j.1464-410X.2011.10485.x
The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
Björn L Isfoss (2011)
10.1016/j.juro.2016.06.049
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.
Sam S. Chang (2016)
10.1016/j.eururo.2016.03.053
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Proto
Seiji Prof Naito (2016)
10.3322/canjclin.39.6.399
Cancer statistics.
N Dubrawsky (1989)
The development of the cystoscope. From "lichtleiter" to fiber optics.
Scott Ww (1969)
10.1117/1.JBO.19.3.036009
Three-dimensional, distendable bladder phantom for optical coherence tomography and white light cystoscopy
Kristen L. Lurie (2014)
10.1016/j.juro.2011.10.131
Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography.
Hugang Ren (2012)
10.1016/S0090-4295(98)00060-0
The Hopkins rod-lens system and the Storz cold light illumination system.
W S Cockett (1998)
10.1016/j.urolonc.2018.04.013
Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
Siamak Daneshmand (2018)
10.1097/MOU.0000000000000078
The burden of bladder cancer care: direct and indirect costs
Matthew Mossanen (2014)
10.1111/J.1464-410X.2007.07317.X
Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder.
Richard T Bryan (2008)



Semantic Scholar Logo Some data provided by SemanticScholar